Coronary Artery Bypass Graft (CABG) within 30 days prior to MI, or CABG procedure planned
Third degree atrioventricular (AV) block or symptomatic bradyarrhythmia
Persistent atrial fibrillation (AF) that is not self terminating within 7 days or is terminated electrically or pharmacologically
Permanent AF that is non self terminating, with cardioversion failed or not attempted within the past year
New York Heart Association (NYHA) Class IV
Non-ischemic cardiomyopathy
Pregnant or planning to become pregnant during the study
Enrolled or planning to participate in a concurrent drug and/or device study during the course of this clinical trial. Co-enrollment in concurrent trials is only allowed with documented pre-approval from Medtronic, documenting that there is not a concern that co-enrollment could confound the results of this trial.
Breast feeding
Of a vulnerable population as determined by local law or requirement, or a physician
Clareo Health | Post-Myocardial Infarction Remodeling Prevention Therapy
